PURE Biosciences Inc (OTCQB:PURE)

0.50
Delayed Data
As of May 21
 +0.01 / +2.04%
Today’s Change
0.34
Today|||52-Week Range
1.22
-7.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$20.0M

Company Description

PURE Bioscience, Inc. is engaged in the discovery, development and commercialization of bioscience products that provide solutions to global health challenges. Its technology platform is based on stabilized ionic silver and its products include PURE, Axen 30, Silverion and Axenohl, which contain silver dihydrogen citrate. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

Contact Information

PURE Bioscience, Inc.
1725 Gillespie Way
El Cajon California 92020-1098
P:(619) 596-8600
Investor Relations:
16195968600111

Employees

Shareholders

Mutual fund holders2.09%
Individual stakeholders17.42%
Other institutional0.61%

Top Executives

Henry R. LambertChief Executive Officer & Director
Peter C. WulffSecretary, Chief Operating & Financial Officer
Bridget TinsleyVice President-Market Development
Tom MyersExecutive VP-Marketing & Product Development
Cliff WechslerExecutive Vice President-Sales

To view my watchlist

Not a member yet?

Sign up now for a free account